187 related articles for article (PubMed ID: 30336979)
1. Role of Dicer in regulating oxaliplatin resistance of colon cancer cells.
Lai HH; Lin LJ; Hung LY; Chen PS
Biochem Biophys Res Commun; 2018 Nov; 506(1):87-93. PubMed ID: 30336979
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
Gao R; Fang C; Xu J; Tan H; Li P; Ma L
Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
[TBL] [Abstract][Full Text] [Related]
4. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
Liao CC; Ho MY; Liang SM; Liang CM
Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
[TBL] [Abstract][Full Text] [Related]
5. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
Zhou S; Peng J; Xiao L; Zhou C; Fang Y; Ou Q; Qin J; Liu M; Pan Z; Hou Z
Cell Death Dis; 2021 May; 12(5):463. PubMed ID: 33966039
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis.
Lai HH; Li JN; Wang MY; Huang HY; Croce CM; Sun HL; Lyu YJ; Kang JW; Chiu CF; Hung MC; Suzuki HI; Chen PS
J Clin Invest; 2018 Feb; 128(2):625-643. PubMed ID: 29251629
[TBL] [Abstract][Full Text] [Related]
7. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
Vaksman O; Hetland TE; Trope' CG; Reich R; Davidson B
Hum Pathol; 2012 Nov; 43(11):2062-9. PubMed ID: 22647351
[TBL] [Abstract][Full Text] [Related]
8. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance.
Zhang C; Huys A; Thibault PA; Wilson JA
Virology; 2012 Nov; 433(2):479-88. PubMed ID: 22999255
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
[TBL] [Abstract][Full Text] [Related]
10. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
11. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
12. Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients.
Chen X; Li WF; Wu X; Zhang HC; Chen L; Zhang PY; Liu LY; Ma D; Chen T; Zhou L; Xu Y; Zhou MT; Tang KF
Carcinogenesis; 2017 Sep; 38(9):873-882. PubMed ID: 28911000
[TBL] [Abstract][Full Text] [Related]
13. The expression of Drosha, DGCR8, Dicer and Ago-2 genes are upregulated in human umbilical vein endothelial cells under hyperglycemic condition.
Soufi FG; Zonouzi AAP; Eftekhar E; Kamali K; Chegeni SA; Zonouzi AP
Endocr Regul; 2018 Jul; 52(3):123-127. PubMed ID: 31517606
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin F
Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
[TBL] [Abstract][Full Text] [Related]
16. Dicer affects cisplatin‑mediated apoptosis in epithelial ovarian cancer cells.
Wang X; Chen H; Wen Y; Yang X; Han Q; Jiang P; Huang Z; Cai J; Wang Z
Mol Med Rep; 2018 Nov; 18(5):4381-4387. PubMed ID: 30221734
[TBL] [Abstract][Full Text] [Related]
17. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
[TBL] [Abstract][Full Text] [Related]
18. Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity.
Herrera-Carrillo E; Harwig A; Liu YP; Berkhout B
RNA; 2014 Sep; 20(9):1410-8. PubMed ID: 25035295
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]